IRhythm's Zio ECG System Gets Approval in Japan, Stock Falls
IRhythm Technologies Announces Japanese Regulatory Approval of the Zio ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence
IRhythm Stock May Gain on Its Latest Deal With BioIntelliSense
IRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio Monitor at HRX 2024 Meeting
Morgan Stanley Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Maintains Target Price $120
Morgan Stanley analyst Kallum Titchmarsh maintains $iRhythm Technologies(IRTC.US)$ with a buy rating, and maintains the target price at $120.According to TipRanks data, the analyst has a success
IRhythm Technologies Strikes Advanced Tech Licensing Deal
Express News | IRhythm : To Pay Biois Upfront Fee of $15.0 Million in Cash Upon Co's Acceptance of Initial Transfer of Certain Data Post Execution of Deal
IRhythm Technologies Doesn't Expect to Incur Any Material Incremental Development Expenses in 2024 >IRTC
IRhythm Technologies Backs 2024 Guidance for Rev, Gross Margin, and Adj EBITDA Excluding Transaction >IRTC
Express News | IRhythm Technologies Inc: Biointellisense Will Also Be Eligible to Receive Royalties on Annual Net Sales of Products and Services
IRhythm Technologies Enters License Agreement With BioIntelliSense for Multiparameter Sensor Technology to Be Used in Ambulatory Cardiac Monitoring
Express News | IRhythm Technologies Enters License Agreement With Biointellisense for Multiparameter Sensor Technology to Be Used in Ambulatory Cardiac Monitoring
Irhythm's Wearable Monitor Found Heart Arrhythmias. It Didn't Stop Strokes. -- Barrons.com
Oppenheimer Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Maintains Target Price $145
Oppenheimer analyst Suraj Kalia maintains $iRhythm Technologies(IRTC.US)$ with a buy rating, and maintains the target price at $145.According to TipRanks data, the analyst has a success rate of 53.4%
Oppenheimer Sticks to Their Buy Rating for Irhythm Technologies (IRTC)
Reported Earlier, IRhythm's GUARD-AF Trial Highlights Zio XT Patch for AF Screening in Older Adults: ESC Presentation
Express News | IRhythm Technologies Announces Results of Guard-Af Trial
IRhythm Technologies Announces Results of GUARD-AF Trial
Build-A-Bear Workshop Posts Upbeat Earnings, Joins Affirm, Nutanix, Cooper Companies, Veeva Systems And Other Big Stocks Moving Higher On Thursday
IRhythm Technologies Expands Global Reach With the Launch of Zio Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain